Breaking News: Investing
Berkshire’s operating earnings jump 34%, Buffett buys back no stock and raises cash hoard to $381 billion
Warren Buffett and Greg Abel walkthrough the Berkshire Hathaway Annual Shareholders Meeting in Omaha, Nebraska on May 3, 2025. David A. Grogen | CNBC Warren Buffett’s Berkshire Hathaway reported a sharp rebound in operating profit on Saturday, while its cash pile swelled to a new high with no buybacks. Berkshire’s operating profit generated from the […]
Read More
Shares of breast cancer therapy developer Olema Pharmaceutical could more than double from here
Wall Street is optimistic that Olema Pharmaceutical could be developing the next major breakthrough breast cancer treatment. Earlier this month, the company announced promising clinical data for its lead candidate palazestrant, an oral medication that is being evaluated in several trials for estrogen receptor-positive, or ER+, breast cancer. Shares of the clinical-stage biopharmaceutical company are up […]
Read More
This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is ‘growing substantially’
It’s been a stellar few months for shares of San Francisco-based biotech company Rigel Pharmaceuticals, which has approved treatments for rheumatology and oncology — as well as potential new drugs in the pipeline. The stock has jumped about 50% in just the last three months, earning it a spot on CNBC’s list of top performing […]
Read More
Corporate travel and expense software firm Navan shares sink by double-digits in first trade after $6 billion Nasdaq IPO
Corporate travel and expense management platform Navan fell by as much as 15% in its first trading day on the Nasdaq under the ticker symbol “NAVN” after its successful initial public offering. The Navan IPO, which priced on Wednesday night, valued the business-to-business software vendor at $6.2 billion, raising $923 million and with shares settling […]
Read More
Navan IPO lands rare one-person venture capital firm its biggest win ever, a $1 billion payday
It wasn’t a traditional pitch meeting. There were no slides, no product demo. There wasn’t even a clear explanation of what the founders were trying to build. But for investor Oren Zeev’s decision-making process, none of that was necessary. “I just liked them, I just wanted to be close to them,” said Zeev. “So I […]
Read More
Ray Dalio says a risky AI market bubble is forming, but may not pop until the Fed tightens
Bridgewater Associates founder Ray Dalio on Tuesday warned that a bubble could be forming around megacap technology in the U.S. amid the artificial intelligence boom, but said that it may not end until the Federal Reserve reverses its current easy policies. “There’s a lot of bubble stuff going on,” Dalio told CNBC’s Sara Eisen in […]
Read More
‘We’re trying to shame them’: Upstart activist investors target America’s underperforming banks
Key Points Hedge fund HoldCo has emerged from relative obscurity to launch activist investor campaigns against three regional banks: Comerica, Eastern Bank and First Interstate. Founders Vik Ghei and Misha Zaitzeff tell CNBC exclusively about their next target, Columbia Bank, and their broader plans to challenge banking CEOs. The millennial upstarts are bringing activism back […]
Read More